Estee Lauder shares declined on Thursday, after the cosmetics & skincare company reported better-than-anticipated earnings, but provided guidance below expectation.
For the three months ended Sept. 30, the company’s earnings came in at $1.61 a share, exceeding the $1.60 a share expected by analysts. The figure is also higher than the year-ago quarter’s $1.34 a share.
Revenue of $3.9 billion is up from $3.5 billion a year ago. It is also higher than analysts' forecasts.
CEO Fabrizio Freda indicated that strong international sales, particularly in China and other emerging markets, as well as within the company's skin care category, travel retail and online channels bolstered earnings for the quarter.
However, Estee Lauder now expects second-quarter earnings per share in the range of $1.83 to $1.86, and full-year per-share earnings of $5.85 to $5.93 - both the ranges are below analysts' forecasts. The company is cautious about potential global uncertainties like those related to the U.S.-China trade war, Brexit, and currency volatility. Also, it will be taking charges associated with previously approved restructuring and other activities of around $110 million to $125 million in fiscal, equal to between 24 cents and 27 cents a share – as indicated by the company.
The Moving Average Convergence Divergence (MACD) for EL turned positive on June 16, 2025. Looking at past instances where EL's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 197 cases where EL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EL broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.542) is normal, around the industry mean (17.380). P/E Ratio (117.853) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (3.832). Dividend Yield (0.017) settles around the average of (0.107) among similar stocks. P/S Ratio (3.617) is also within normal values, averaging (116.662).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which offers skin care, makeup, fragrance and hair care products
Industry HouseholdPersonalCare